View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2...

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Tuesday, May 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on May 7th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-register f...

Texas Pacific Land Corp: 1 director

A director at Texas Pacific Land Corp bought 12 shares at 1,679.180USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

MGM Resorts International: Update following affirmation of B1 CFR and ...

Our credit view of this issuer reflects its good liquidity with sizable cash balances and its large scale and dominant presence in Las Vegas, constrained by its high leverage level.

Moody's rates MGM Resorts International proposed senior unsecured note...

Moody's Ratings (Moody's) today assigned a B1 rating to MGM Resorts International's ("MGM") proposed $750 million senior unsecured notes. The company's existing ratings, including the B1 Corporate Family Rating ("CFR") and B1-PD Probability of Default Rating ("PDR") remain unchanged. MGM's Speculati...

Continental Resources, Inc.: Debt reduction bolsters credit profile

Our credit view of this issuer reflects its high operating and capital efficiency, constrained by its elevated level of debt, pending further reduction in 2024.

Moody's announces completion of a periodic review of ratings of Contin...

Moody's Ratings has completed a periodic review of the ratings of Continental Resources, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 14 March 2024 in which Moody's reassessed the appropriateness of the ratings in the conte...

Opko Health Inc: 1 director

A director at Opko Health Inc bought 500,000 shares at 0.874USD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: March 18, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Moody's affirms MGM Resorts B1 CFR, changes MGM China outlook to stabl...

Moody's Ratings (Moody's) today affirmed MGM Resorts International's ("MGM") B1 Corporate Family Rating ("CFR"), B1-PD Probability of Default Rating, and B1 senior unsecured notes. Moody's also affirmed MGM China Holdings Limited's ("MGM China") senior unsecured notes rating at B1. MGM China is a 55...

MGM Resorts International: 1 director

A director at MGM Resorts International sold 425,000 shares at 42.919USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: March 14, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: March 9, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX...

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV • Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans• Candidate showed similar half-life to standard monoclonal antibodies and minimal anti-drug antibodies WESTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced results from a Phase 1 clinical study of SAR441236, its trispecific broadly neutralizing ant...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch